DUBLIN , Oct. 6, 2022 /PRNewswire/ -- The "Continence Care Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031" report has been added to  ResearchAndMarkets.com's offering.

This report on the global continence care market studies the past as well as current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2031.

The report provides the overall revenue of the global continence care market for the period 2017-2031, considering 2020 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global continence care market for the forecast period. The report has been prepared after an extensive research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the global continence care market. Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts also employed a combination of top-down and bottom-up approaches to study various phenomena in the global continence care market. The report comprises an elaborate executive summary, along with a snapshot of the growth behavior of various segments and sub-segments included in the scope of the study. Additionally, the report sheds light on the changing competitive dynamics in the global continence care market.

These indices serve as valuable tools for existing market players as well as for entities interested in participating in the global continence care market. The next section of the continence care market report highlights the USPs, which includes, COVID-19 pandemic impact on industry (value chain and short/mid/long term impact), technological advancements, pricing analysis, reimbursement scenario by region/globally, key industrial events (licensing partnership/merger & acquisition), and Porter's five force analysis. The report delves into the competition landscape of the global continence care market. Key players operating in the global continence care market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players profiled in the continence care market in report. Key Questions Answered in Continence Care Market Report

What are the sales/revenue generated by continence care across the globe during the forecast period?

What are the key trends in the global continence care market?

What are the major drivers, restraints, opportunities, and threats in the market?

Which region is set to expand at the fastest CAGR during the forecast period?

Which segment will have the highest revenue in 2031 and which segment will grow at the highest CAGR during the forecast period?

Which is the most attractive market in terms of product type, indication, end-user, and region during 2021-2031?

Key Topics Covered: 1. Preface 2. Assumptions and Research Methodology 3. Executive Summary: Global Continence Care Market 4. Market Overview 4.1. Introduction 4.1.1. Segment Definition 4.2. Overview 4.3. Market Dynamics 4.3.1. Drivers 4.3.2. Restraints 4.3.3. Opportunities 4.4. Global Continence Care Market Analysis and Forecast, 2017-2031 4.4.1. Market Revenue Projections (US$ Mn) 5. Key Insights 5.1. Technological Advancements 5.2. Pricing Analysis 5.3. Reimbursement Scenario, by Region/globally 5.4. Key Industrial Events (licensing partnership/merger & acquisition) 5.5. COVID-19 Impact Analysis 5.6. Porter's Five Force Analysis 6. Global Continence Care Market Analysis and Forecast, by Product Type 6.1. Introduction & Definition 6.2. Key Findings / Developments 6.3. Market Value Forecast, by Product Type, 2017-2031 6.3.1. Urinary Catheters 6.3.1.1. External Catheters 6.3.1.2. Indwelling Catheters 6.3.1.3. Intermittent Catheters 6.3.1.4. Catheter Accessories 6.3.2. Male Bodyworn Urinals 6.3.3. Mechanical Devices for Women with Urinary Incontinence 6.3.3.1. Urethral Inserts 6.3.3.2. Intravaginal Devices 6.3.4. Urine Drainage Bags & Accessories 6.3.4.1. Leg Drainage Bags 6.3.4.2. Night Drainage Bags 6.3.4.3. Accessories 6.3.5. Absorbents 6.3.6. Penile Clamps 6.3.7. Non-implantable Electrical Stimulation Devices 6.3.8. Others 6.4. Market Attractiveness Analysis, by Product Type 7. Global Continence Care Market Analysis and Forecast, by Indication 7.1. Introduction & Definition 7.2. Key Findings / Developments 7.3. Market Value Forecast, by Indication, 2017-2031 7.3.1. Urge Urinary Incontinence (UUI) 7.3.2. Stress Urinary Incontinence (SUI) 7.3.3. Mixed Urinary Incontinence (MUI) 7.3.4. Others 7.4. Market Attractiveness Analysis, by Indication 8. Global Continence Care Market Analysis and Forecast, by End-user 8.1. Introduction & Definition 8.2. Key Findings / Developments 8.3. Market Value Forecast, by End-user, 2017-2031 8.3.1. Acute Care Facilities 8.3.2. Long Term Care Facilities 8.3.3. Homecare 8.3.4. Others 8.4. Market Attractiveness Analysis, by End-user 9. Global Continence Care Market Analysis and Forecast, by Region 9.1. Key Findings 9.2. Market Value Forecast, by Region 9.2.1. North America 9.2.2. Europe 9.2.3. Asia Pacific 9.2.4. Latin America 9.2.5. Middle East & Africa 9.3. Market Attractiveness Analysis, by Country/Region

10. North America Continence Care Market Analysis and Forecast

11. Europe Continence Care Market Analysis and Forecast

12. Asia Pacific Continence Care Market Analysis and Forecast

13. Latin America Continence Care Market Analysis and Forecast

14. Middle East & Africa Continence Care Market Analysis and Forecast

15. Competitive Landscape 15.1. Market Share Analysis of Key Companies, by Region (2020) 15.2. Company Profiles 15.2.1. Abena A/S 15.2.1.1. Company Overview (HQ, Business Segments, Employee Strength) 15.2.1.2. Product Portfolio 15.2.1.3. Strategic Overview 15.2.1.4. SWOT Analysis 15.2.2. Atlantic Therapeutics 15.2.2.1. Company Overview (HQ, Business Segments, Employee Strength) 15.2.2.2. Product Portfolio 15.2.2.3. Strategic Overview 15.2.2.4. SWOT Analysis 15.2.3. Attends Healthcare Products, Inc. 15.2.3.1. Company Overview (HQ, Business Segments, Employee Strength) 15.2.3.2. Product Portfolio 15.2.3.3. Strategic Overview 15.2.3.4. SWOT Analysis 15.2.4. B. Braun Melsungen AG 15.2.4.1. Company Overview (HQ, Business Segments, Employee Strength) 15.2.4.2. Product Portfolio 15.2.4.3. Financial Overview 15.2.4.4. Strategic Overview 15.2.4.5. SWOT Analysis 15.2.5. Beambridge Medical Ltd. 15.2.5.1. Company Overview (HQ, Business Segments, Employee Strength) 15.2.5.2. Product Portfolio 15.2.5.3. Strategic Overview 15.2.5.4. SWOT Analysis 15.2.6. Becton, Dickinson and Company 15.2.6.1. Company Overview (HQ, Business Segments, Employee Strength) 15.2.6.2. Product Portfolio 15.2.6.3. Financial Overview 15.2.6.4. Strategic Overview 15.2.6.5. SWOT Analysis 15.2.7. Boston Scientific Corporation 15.2.7.1. Company Overview (HQ, Business Segments, Employee Strength) 15.2.7.2. Product Portfolio 15.2.7.3. Strategic Overview 15.2.7.4. SWOT Analysis 15.2.8. Coloplast A/S 15.2.8.1. Company Overview (HQ, Business Segments, Employee Strength) 15.2.8.2. Product Portfolio 15.2.8.3. Financial Overview 15.2.8.4. Strategic Overview 15.2.8.5. SWOT Analysis 15.2.9. ConvaTec Group PLC 15.2.9.1. Company Overview (HQ, Business Segments, Employee Strength) 15.2.9.2. Product Portfolio 15.2.9.3. Financial Overview 15.2.9.4. Strategic Overview 15.2.9.5. SWOT Analysis 15.2.10 . Drylock Technologies 15.2.10.1. Company Overview (HQ, Business Segments, Employee Strength) 15.2.10.2. Product Portfolio 15.2.10.3. Strategic Overview 15.2.10.4. SWOT Analysis 15.2.11 . Hollister Incorporated 15.2.11.1. Company Overview (HQ, Business Segments, Employee Strength) 15.2.11.2. Product Portfolio 15.2.11.3. Strategic Overview 15.2.11.4. SWOT Analysis 15.2.12 . InControl Medical LLC 15.2.12.1. Company Overview (HQ, Business Segments, Employee Strength) 15.2.12.2. Product Portfolio 15.2.12.3. Strategic Overview 15.2.12.4. SWOT Analysis 15.2.13 . Kimberly-Clark Corporation 15.2.13.1. Company Overview (HQ, Business Segments, Employee Strength) 15.2.13.2. Product Portfolio 15.2.13.3. Financial Overview 15.2.13.4. Strategic Overview 15.2.13.5. SWOT Analysis 15.2.14 . Optimum Medical Limited 15.2.14.1. Company Overview (HQ, Business Segments, Employee Strength) 15.2.14.2. Product Portfolio 15.2.14.3. Strategic Overview 15.2.14.4. SWOT Analysis 15.2.15 . Pacey MedTech Ltd. 15.2.15.1. Company Overview (HQ, Business Segments, Employee Strength) 15.2.15.2. Product Portfolio 15.2.15.3. Strategic Overview 15.2.15.4. SWOT Analysis 15.2.16 . Renew Medical, Inc. 15.2.16.1. Company Overview (HQ, Business Segments, Employee Strength) 15.2.16.2. Product Portfolio 15.2.16.3. Strategic Overview 15.2.16.4. SWOT Analysis 15.2.17 . Uresta 15.2.17.1. Company Overview (HQ, Business Segments, Employee Strength) 15.2.17.2. Product Portfolio 15.2.17.3. Strategic Overview 15.2.17.4. SWOT Analysis 15.2.18 . Urocare Products, Inc. 15.2.18.1. Company Overview (HQ, Business Segments, Employee Strength) 15.2.18.2. Product Portfolio 15.2.18.3. Strategic Overview 15.2.18.4. SWOT Analysis 15.2.19 . Vesiflo, Inc. 15.2.19.1. Company Overview (HQ, Business Segments, Employee Strength) 15.2.19.2. Product Portfolio 15.2.19.3. Strategic Overview 15.2.19.4. SWOT Analysis For more information about this report visit https://www.researchandmarkets.com/r/s1pi4f

Research and Markets Laura Wood , Senior Manager press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904 Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

View original content:https://www.prnewswire.com/news-releases/outlook-on-the-continence-care-global-market-to-2031---by-product-type-indication-end-user-and-region-301642512.html

Oil prices have bounced around quite a bit this year. Brent oil, the global-pricing benchmark, started 2022 below $80 a barrel before soaring into the $120s following Russia's invasion of Ukraine. With the prospect of higher oil prices, we asked some of our energy contributors what oil stocks they believe are best positioned to capitalize following OPEC's bold move.

Intel (NASDAQ: INTC) has been under tremendous pressure this year. Shares of the semiconductor company have tumbled about 50%. While Intel is facing its share of headwinds, I believe better days lie ahead for the tech giant and its big-time dividend.

The three stocks that stood out to me are Taiwan Semiconductor (NYSE: TSM), Disney (NYSE: DIS), and Adobe (NASDAQ: ADBE). The company is a third-party manufacturer for chip leaders like Apple (NASDAQ: AAPL), Nvidia (NASDAQ: NVDA), and dozens of other companies designing their own chips.

Tax-loss harvesting has risen in popularity. BofA says the strategy could give a boost to underperforming stocks from November to January.

The year 2022 has been a painful journey for semiconductor manufacturers. Following the example of AMD , Nvidia and Intel , which are the three main players in the sector, 2022 is a year to forget .Their valuations are in recession. Advanced Micro Devices (AMD) currently has a market value of $94.4 billion, which is a decrease of at least $83 billion compared to December 31, 2021.

The veteran telecom company is having a stellar year in many respects, but reason for concern has emerged.

Investing in Warren Buffett's biggest holdings can be a winning tactic, but don't overlook the companies that occupy smaller positions in Berkshire Hathaway's portfolio.

You would think this would be TIPS’ time to shine. Instead, the prices of Treasury inflation-protected securities—government bonds that are adjusted to keep up with inflation—have declined this year, even as inflation has soared. The comparable loss for ICE’s index of regular Treasury bonds was 13.5%.

NIO Inc. stock is trending on the Yahoo Finance Platform. Here is a visualization of $NIO performance over time, how that performance compares to the wider industry, and analyst projections for the current quarter.Check out the ticker page here.

PayPal is in trouble. "You are independently responsible for complying with all applicable laws in all of your actions related to your use of PayPal's services, regardless of the purpose of the use," the document, called "Acceptable Use of Policy," said.

This indicator has correctly predicted five steep stock market declines since 1870 -- and it's highly successful at calling bottoms, too!

For the retail investor, the only certainty of our current market environment is uncertainty. Volatility is up, and the main indexes are showing deepening losses. As if that wasn't enough, at least one market bull is turning a bit more pessimistic. JPMorgan strategist Marko Kolanovic has been one of the more bullish voices on Wall Street in recent months, but current conditions have him pushing the timeline back. While he still believes that the S&P 500 can hit 4,800, or a 32% gain from current

Luckily for everyday investors like us, institutions that trade stocks need to disclose their transactions to the Securities and Exchange Commission every three months. Ray Dalio's hedge fund, Bridgewater Associates, made a relatively large bet on CVS Health (NYSE: CVS) stock in the second quarter. It's CVS' less visible business segments that have allowed it to more than triple its dividend payout over the past decade.

The company's longtime CEO announced his retirement, leading some analysts to contemplate a cut to the 14% dividend.

The first quarter of 2022 has been difficult for retirement savers and retirees alike, and according to investment firm Charles Schwab, it was one of the worst quarters for fixed-income in decades. However, the rising yields and changed Federal Reserve … Continue reading → The post Charles Schwab Says Now Is the Time to Add This Asset to Your Retirement Portfolio appeared first on SmartAsset Blog.

It may not be practical — at least for now.

A market rally attempt is reeling as the indexes plunged on Friday's jobs report. Tesla, AMD and On Semi sold off.

The company is reaping benefits from investments in 5G technology, but that's not necessarily enough to make AT&T stock a buy.

Should I buy stocks now or wait? That's a question many investors are asking themselves right now.

Usually Amazon is the tech leader, but Walmart may actually have an edge that will help customers get what they want faster.